ClinicalTrials.Veeva

Menu

Prevention of Intra-uterine Adhesions Following Laparoscopic and Laparotomic Myomectomy (PALLM)

G

Ghent University Hospital (UZ)

Status

Enrolling

Conditions

Myoma

Treatments

Device: Hyalobarrier

Study type

Interventional

Funder types

Other
Industry

Identifiers

NCT05683041
ONZ-2022-0355

Details and patient eligibility

About

Clinical study on the prevention of intrauterine adhesions after laparoscopic or laparotomic myomectomy.

Myomas are common in women of reproductive age and myomectomy can lead to intra-uterine adhesions, which can be detrimental to fertility. This study investigates whether the use of an intrauterine gel can prevent the development of these adhesions.

Full description

Design:

Double-blind, randomized controlled pilot trial.

Participant:

  • age between 18 and 45 years.
  • intramurale and/or subserosal myoma (FIGO 3-6), and/or hybrid myoma (with a connection to the endometrium and serosa (FIGO 2-5), who are scheduled for laparoscopic / laparotomic myomectomy.
  • absence of intra-uterine adhesions on preoperative diagnostic hysteroscopy

Treatment:

Application of intrauterine Hyalobarrier® gel endo at time of surgery

Control:

No application of Hyalobarrier® gel endo

Follow up:

Second-look hysteroscopy after 3months

To blind all trial participants and gynaecologists doing second-look hysteroscopy, 10 ml of a sterile ultrasound gel will be applied into the vagina at the end of the procedure in all women regardless of their treatment allocation.

Enrollment

30 estimated patients

Sex

Female

Ages

18 to 45 years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • age between 18 and 45 years.
  • intramurale and/or subserosal myoma (FIGO 3-6), and/or hybrid myoma (with a connection to the endometrium and serosa (FIGO 2-5), who are scheduled for laparoscopic / laparotomic myomectomy.
  • absence of intra-uterine adhesions on preoperative diagnostic hysteroscopy

Exclusion criteria

  • pregnancy.
  • laparoscopic or laparotomic myomectomy in combination with an operative hysteroscopy.
  • presence of endometritis.
  • other antiadhesion methods

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

30 participants in 2 patient groups

intrauterine gel application
Experimental group
Description:
Application of Hyalobarrier intrauterine after myomectomy.
Treatment:
Device: Hyalobarrier
no intra-uterine gel application
No Intervention group
Description:
No application of Halobarrier intrauterine after myomectomy.

Trial contacts and locations

1

Loading...

Central trial contact

Steven Weyers, Prof. dr.; Steffi Van Wessel, Dr.

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems